Artificial Intelligence: The New Doctor in Personalized Medicine

Abstract: Personalized medicine (PM) offers a significant possibility for enhancing the future of tailored healthcare. This article assesses the challenges and opportunities that multi-omics research faces globally to advance personalized medicine. It provides a broad review of these issues. AI has improved the healthcare possibilities for emerging innovations including artificial intelligence (AI), and it initiates a discussion amongst essential projects in this field. Without inquiry, artificial intelligence (AI) is the most widely debated topic in healthcare imaging studies, both diagnostically and therapeutically. AI has remained applied toward radiation oncology image modalities for objectives such as therapy evaluation and tumor delineation. It provides considerable promise for increased effectiveness and efficiency, as well as in the pharmaceutical sector is no exception. The use of AI technology for assessing and analyzing several crucial pharmacy disciplines, such as drug research, dosage form design, poly-pharmacy, and hospital pharmacy, has garnered a great deal of attention in the last few decades. The difficulty is in efficiently evaluating large volumes of data to provide specific treatment strategies. The infrastructure of healthcare requires modifications to integrate AI into personalized care. With authorization, patient's personal information and clinical data—such as imagery, electrophysiological results, genetic details, arterial pressure, medical records, etc.—are incorporated into the AI system upon their accession. The AI system then makes use of this individual patient's information to provide advice for healthcare, enabling healthcare staff to make clinical assessments. AI also enables predictive modeling, drug discovery, and precision medicine, ultimately revolutionizing how healthcare is delivered.